Login / Register

Username:


Password: [Lost?]



New User? Click here for your FREE subscription



Healthcare Professionals
Healthcare Professionals Healthcare Professionals

Follow Us


NEWS-Line on Twitter NEWS-Line on Facebook NEWS-Line on Google+ NEWS-Line on LinkedIn NEWS-Line on Pinterest


Healthcare Conferences &
Educational Opportunities









Ongoing

Primary Care Focus Symposium Online

Baptist Health South Florida

Ongoing

Skin, Bones, Hearts & Private Parts - CME NOW OnDemand

Skin, Bones, Hearts & Private Parts

March 16 - 18

2022 LAPA Annual CME Conference

LOUISIANA ACADEMY PHYSICIAN ASSISTANTS

March 24 - 27

5th Annual Symposium Early Disease Detection & Disease Prevention in Family Practice

ASSOCIATION OF FAMILY PRACTICE PAs & NPs AFPPANP

April 24 - 29

42nd Annual Refresher/Re-Certification Course

SOCIETY OF ARMY PHYSICIAN ASSISTANTS SAPA

More Events

Over 4 Million Deaths Per Year Caused By Obesity - Safe, Non-Invasive Obesity Treatments Could Help End Epidemic | NEWS-Line for Occupational Therapists & COTAs
 


Over 4 Million Deaths Per Year Caused By Obesity - Safe, Non-Invasive Obesity Treatments Could Help End Epidemic


Source:

Novel obesity treatments such as modulation of the gut microbiome and gene therapy are underutilized and could help fight the obesity epidemic, according to a new manuscript published in the Endocrine Society’s journal, Endocrine Reviews.

Nearly half of the adults and 20 percent of children in the United States have obesity, yet doctors are under prescribing effective weight loss medications and many patients are not receiving the treatment they need. The weight stigma that exists in healthcare settings makes people with obesity hesitant to seek care until comorbidities develop and reach a dangerous stage. Lack of insurance coverage and cost issues are another factor that creates barriers to obesity treatment.

“Obesity is the epidemic crisis of our time. The disease leads to serious comorbidities such as diabetes, fatty liver disease and cardiovascular disease and significantly shortens a person’s length and quality of life,” said Christos S. Mantzoros, M.D., Sc.D., of Beth Israel Deaconess Medical Center in Boston, Mass. “Until recently we did not understand the genetic and hormonal causes of obesity and how obesity leads to these comorbidities. We have recently started to understand the causes of obesity in humans, which is a big discovery that has led to designing effective therapies.”

In the article, the researchers map out the molecular and hormonal pathways that lead to obesity and the disease’s related comorbidities. This data gives researchers the insights they need to design, test and implement new obesity therapies.

The researchers highlight the need for safer and more effective obesity therapies, including new drug delivery systems, vaccines, modulation of the gut microbiome and gene therapy. Novel medications, including combinations of gastrointestinal hormones and other molecules, are being tested and are expected to lead to significant percentages of weight loss with less side effects once available. As our understanding of obesity improves, more effective medications with fewer side effects will be developed.

Recently approved medications such as semaglutide, a modified gastrointestinal hormone administered once a week, can lead to 15% weight loss when combined with lifestyle changes. Bariatric surgery can lead to up to 40% weight loss, but it is invasive and linked to complications.

"Insurance companies need to pay attention to data from studies and the scientific progress we are making and start covering the medications that are and will be approved soon, given that currently only a small minority of patients with obesity have coverage for the medications and medical care they need,” Mantzoros said. “It would be much more cost effective to cover treatments early instead of waiting for comorbidities and their complications to develop.”

Other authors of the study include: Angeliki Angelidi and Matthew Belanger of Harvard Medical School in Boston, Mass., and Alexander Kokkinos and Chrysi Koliaki of Laiko General Hospital in Athens, Greece.

The research received no external funding.

The manuscript, “Novel Non-invasive Approaches to the Treatment of Obesity: From Pharmacotherapy to Gene Therapy,” was published online, ahead of print.

Endocrinologists are at the core of solving the most pressing health problems of our time, from diabetes and obesity to infertility, bone health, and hormone-related cancers. The Endocrine Society is the world’s oldest and largest organization of scientists devoted to hormone research and physicians who care for people with hormone-related conditions.

The Society has more than 18,000 members, including scientists, physicians, educators, nurses and students in 122 countries. To learn more about the Society and the field of endocrinology, visit our site at www.endocrine.org Follow us on Twitter at @TheEndoSociety and @EndoMedia

Source: The Endocrine Society





Post not cached because it doesn't exist


Share This!


Healthcare Jobs


Full-Time Pediatrics Speech Language Pathologist - No weekends, holidays or on-call - Up to a $15,000 Sign-on Bonus (Based on Experience) - Relocation assistance negotiable

Genesis Healthcare System
Zanesville, Ohio

Respiratory Therapist Opportunities for Experienced RRTs and New Grads! - Positions working with Adults and in Neonatal/Pediatrics - $20,000 Sign-On Bonus for Experienced RRTs - $10,000 Sign-On Bonus for New Grads - Relocation Assistance Available!

Carilion Clinic
Roanoke, Virginia

Night shift Nurse

OUR HOUSE OF PORTLAND
Portland, OR

On-Call Caregiver

OUR HOUSE OF PORTLAND
Portland, OR

Flex Certified Nursing Assistant (CNA) or Caregiver

OUR HOUSE OF PORTLAND
Portland, OR

Caregiver

OUR HOUSE OF PORTLAND
Portland, OR

More Jobs
(Dismiss) Thank you for visiting NEWS-Line! Please sign up, login, or follow us on your favorite social networks
to receive custom tailored eNews, job listings, and educational opportunities for your specific profession.